Tulane Home Tulane Shield logo linking to site home page

Inroads E-Newsletter

 

November 2022

Two Million Life-Years / $21 Billion in Earnings Lost Annually Due to Smoking-Associated Cancer Deaths

 

ACS Life Years Lost
A new study led by researchers at the American Cancer Society (ACS) reports nearly 123,000 cancer deaths, or close to 30 percent of all cancer deaths, were from cigarette smoking in the United States in 2019, leading to more than two million Person-Years of Lost Life (PYLL) and nearly $21 billion in annual lost earnings. These losses were disproportionately higher in states with weaker tobacco control policies in the South and Midwest. The results were published in the International Journal of Cancer.

“Our study provides further evidence that smoking continues to be a leading cause of cancer-related death and to have a huge impact on the economy across the U.S.,” said Dr. Farhad Islami, senior scientific director, cancer disparity research at the American Cancer Society and lead author of the study. “We must continue to help individuals to quit using tobacco, prevent anyone from starting, and work with elected officials at all levels of government for broad and equitable implementation of proven tobacco control interventions.”

For the study, the authors estimated the proportions and numbers of cigarette smoking-attributable cancer deaths and associated PYLL and lost earnings among individuals, aged 25-79 years, in 2019 in the U.S. nationally and by state. As smoking-attributable cancer deaths occur more commonly in individuals with lower socioeconomic status, they used education-specific data for each state to account for variations in employment status, wages, and smoking-attributable mortality by socioeconomic status. Cancers associated with cigarette smoking that were evaluated in this study included cancers of the mouth, pharynx, esophagus, stomach, colorectum, liver and intrahepatic bile duct, pancreas, larynx, lung and bronchus, cervix, kidney and renal pelvis, urinary bladder, and acute myeloid leukemia.

The study results showed death rates were highest in the 13 states with generally weaker tobacco control policies and higher cigarette smoking prevalence. These states include Alabama, Arkansas, Indiana, Kentucky, Louisiana, Michigan, Mississippi, Missouri, Ohio, Oklahoma, South Carolina, Tennessee, and West Virginia. Also, the annual PYLL rate for these states was 46.8% higher than in other states and the District of Columbia (1,431 per 100,000 population compared to 975 per 100,000). In addition, the lost earnings rate for these states was 44% higher ($11.2 million per 100,000 population compared to $7.8 million per 100,000) than in other states and the District of Columbia.

The study also found that if PYLL and lost earning rates in Utah (the state with the lowest PYLL rate) had been achieved by all states, more than half of the estimated total PYLL and lost earnings in 2019 nationally would have been avoided. The proportion of avoidable PYLL and lost earnings by state exceeded 50% in 39 states and the District of Columbia for PYLL and in 30 states for lost earnings.

“Increasing the price of cigarettes through excise taxes is the single most effective policy for reducing smoking. In many states, state tobacco excise tax rates remain low, particularly in the states with the highest smoking rates,” said Dr. Ahmedin Jemal, senior vice president, surveillance and health equity science at the American Cancer Society, and senior author of the study. “Eliminating existing gaps in Medicaid and private insurance coverage of cessation services is an important intervention to reduce smoking-related cancers. This would also provide access to all types of counseling and all medications approved by the FDA without cost-sharing to the patient.”

“This report further demonstrates just how critical reducing tobacco use is to ending suffering and death from cancer,” said Lisa Lacasse, president of the American Cancer Society Cancer Action Network (ACS CAN), the advocacy affiliate of the American Cancer Society. “To end the scourge of tobacco on this country, reduce the health disparities it inflicts, and decrease tobacco-related diseases like cancer, we need local, state, and federal lawmakers to pass proven tobacco control policies, including regular and significant tobacco tax increases, comprehensive statewide smoke-free laws, adequate funding for state tobacco prevention and cessation programs and ensure all Medicaid enrollees have access to comprehensive tobacco cessation services including all three types of counseling and all FDA-approved medications. We have the tools to get this done, we just need lawmakers to act.”

ACS Earnings Lost


Tulane's Low-Dose CT Lung Screening Saves Lives
 

Mark Sides MD

According to the American Cancer Society, lung cancer (both small cell and non-small cell) is the second most common cancer in both men and women, and is by far the leading cause of cancer death, accounting for almost a quarter of all cancer deaths. Each year, more people die of lung cancer than of colon, breast, and prostate cancers combined.
 
On a positive note, lung cancer incidence and mortality continue to decrease, partly because more people have given up smoking, but also because of advances in early detection and treatment.
 
Low-dose CT lung cancer screenings – offered at Tulane Lakeside and Tulane Medical Center – can help detect lung cancers at their earliest stages, when they are most treatable.
 
"The earlier you find the cancer, the better the prognosis," said Mark Sides, MD, PhD, head of Tulane's Thoracic Oncology Program. "This screening can save your life. Five-year survival rates go down dramatically with each stage of the disease. If we can catch stage 1 – when lung cancer is typically asymptomatic – then it's a surgical issue. The surgeon goes in, removes the tumor and the patient is cured."
 
Patients at high risk for lung cancer who may benefit from CT screening:

  •     Are between the ages of 50 and 80
  •     Are current smokers or quit within the last 15 years
  •     Have a 20-pack-year history of smoking

In addition to the above characteristics, individuals are considered to be at high risk for lung cancer if they also have any ONE of the following risk factors:

  •     Documented high radon exposure
  •     Occupational exposure to silica, cadmium, asbestos, arsenic, beryllium, chromium, nickel or diesel fumes
  •     Survivor of lung cancer, lymphoma, or head and neck cancer
  •     History of chronic obstructive pulmonary disease or pulmonary fibrosis
  •     Family history of lung cancer

Secondhand smoke exposure is NOT an independent risk factor for lung cancer CT screening.

This non-invasive, painless test only takes a few minutes. Radiation exposure from low-dose CT is slightly more than an x-ray but less than 10% of the radiation from a standard CT scan. "Anything actionable will be picked up with much less radiation," said Dr. Sides. "If a detected lesion is below a certain size, we simply watch it, do serial screenings, and if it doesn't change, it doesn't change. It's very unlikely it's cancer."
Most insurance providers cover low-dose CT lung cancer screening for patients who meet the high-risk criteria listed above. Please check with your insurance provider to confirm screening coverage.

A CT scan requires a physician's order. If you are interested in a low-dose CT screening, please call 504-988-1200 or have your doctor call with a referral.

For more information, please contact the Tulane Lung Nodule Nurse Navigator at 504-988-2247.


WWL Highlights World's First Breast Cancer Survivor Helped by Technology Born at Tulane

The very first woman to benefit from breakthrough areola reconstruction talks about this life-changing technology.  To view the video, please click here.


Robes Provide Comfort to Breast Cancer Patients at Tulane

Robes

The Karen T. Stall Research & Breast Institute donated these robes to make Tulane breast cancer patients feel more comfortable while undergoing treatments and exams. (Story by Bethany Barnoski; photo by Cheryl Gerber)

 

Karen T. Stall knows the anxiety and stress that comes with a cancer diagnosis and treatment. A survivor of breast cancer, Stall made it her mission to help other patients going through that same experience. Her foundation, the Karen T. Stall Research and Breast Institute, partners with healthcare facilities across the Gulf South including Tulane Doctors Breast Cancer Center. The foundation recently donated 113 robes to make Tulane patients feel more comfortable and at ease.

The plush waffle robes are available at Tulane Doctors-Surgical Oncology Northshore Clinic and Tulane Lakeside Hospital. Being surrounded in comfort while in the clinic has had a significant impact on how patients feel when they are receiving treatments, and some have even commented that they feel relaxed.

"I am so grateful we have these robes," said Caroline Graham, PA-C, an instructor of surgery in the Division of Oncologic Surgery at Tulane University School of Medicine. "Many clinic gowns don't provide full coverage, and these robes are very soft and provide full closure. It's similar to being at a spa or a robe they would wear at home."

 

Tulane Doctors Breast Cancer Center offers state-of-the-art care for overall breast health. Tulane offers 3D Tomosynthesis imaging, which has become the gold standard for breast cancer screening because it can detect cancer earlier than traditional 2D screening. The Karen T. Stall Research and Breast Institute is focused on making sure all patients have access to this better imaging. You can donate to their mission here.


Blue Ribbon Soirée Surpasses $1 Million Mark in Funds Raised for Prostate Cancer Research

BRS2022

Brad and Jo Lanehart, Lourdes and Jeff Kadair, and Frances and Gary McConnell have been generous sponsors of the Blue Ribbon Soiree since its first year. (Photos by In Register)
 

The 11th Annual Blue Ribbon Soirée, held October 20 at the Baton Rouge Renaissance Hotel, raised a record $170,000, propelling the organization to a cumulative $1.25 million raised for prostate cancer research and awareness since its inception.

Soirée was started in 2011 by the friends and families of Drs. Larry Ferachi and Joel Nasca, who sadly lost their battles with prostate cancer. "We founded the Blue Ribbon Soirée to honor these two incredible men," said Ricky Lato, co-chair and co-founder of the organization. "Over the last 11 years, with the support of the community and the hard work of so many committee members, the event has raised over a million dollars for research and awareness. Never did we imagine we'd hit these heights. Nor did we fully understand how our decision to pursue this venture would become one of the most rewarding and fulfilling parts of our lives."

Funds raised through the event benefit Dr. Oliver Sartor's Prostate Cancer Research Program here at Tulane Cancer Center. Drs. Ferachi and Nasca conducted extensive research and traveled the country participating in clinical trials after their diagnoses. They were most impressed with Dr. Sartor, and the Soiree planning committee feels it is important to continue their quest to support Dr. Sartor's research.

"It is difficult to adequately express my gratitude for the support provided by the Blue Ribbon Soirée or the importance of this effort to my team's research progress," said Dr. Sartor. "To have the commitment and resolve of such a tremendously motivated and generous group of volunteers and donors behind us is simply invaluable to our efforts. We know you are with us every step of the way, and that level of encouragement pushes us forward and sharpens our focus each and every day."

"We know Larry and Joel would be proud of what has been accomplished in their names," said Lato.

For more information on the Blue Ribbon Soirée, visit www.blueribbonsoiree.org.
 


 


 

Krewe de Pink "Sweet Survivors"/Others Honored at City Council's Breast Cancer Awareness Day

 The New Orleans City Council recently hosted its annual Breast Cancer Awareness Day, where local survivors, including those previously honored by the grassroots fundraising organization Krewe de Pink at their 2022 Death by Chocolate Not Breast Cancer event, were presented with proclamations from the city. Krewe de Pink honorees in attendance included Chef Grace Landry; Lena Stewart, special projects coordinator for Councilmember Oliver Thomas; Maria Cordoro Stambaugh; and Caitrin Gladow. Michele Goldfarb attended on behalf of Dianne Honore, who was displaying her incredible Mardi Gras Indian costumes at an exhibit in Paris, and Sweet Survivor Chontel Carter was out of town. Carol Osborne, president emeritus of Krewe de Pink, and Matthew Burow, PhD (third from right), whose breast cancer research lab here at Tulane benefits from funds raised by the organization, also joined the festivities.


 

Previous Issues...

October 2022
Machado Awarded $2.4 Million Grant to Study Role of Macrophages in Breast Development
AACR Cancer Progress Report Highlights Advances that Improve, Extend & Save Lives
11th Annual Blue Ribbon Soiree
ACS Patient Transportation Grant Helps Lift Barriers to Cancer Care
Trevino Named Honorary "Shucker" for ACS "Shuck Cancer" Fundraiser
NOLA Bluedoo Fest Raises Awareness & $170K for Prostate Cancer Research
Artist-In-Residence / MedArt Volunteers Celebrate Completion of Clinic Mural

September 2022
NOLA Bluedoo Fest Returns
COVID-19 Pandemic Reduced Breast, Cervical, Colorectal Cancer Screenings by Millions in 2020
Tulane Cancer Center Comprehensive Clinic Mural Progress Report
Learn Everything You Want to Know About Prostate Cancer - From the Experts
Cancer Crusaders to Honor Cancer Survivors at Annual Luncheon
Krewe de Pink Holds Pink Prom

August 2022
It's Bluedoo Time!
Tulane Cancer Center Faculty Members Named 'Top Doctors' in New Orleans
Newly Revealed Data Suggests Rates of a Rare Skin Cancer Are Increasing in Louisiana
Learn Everything You Want to Know About Prostate Cancer - From the Experts

July 2022
Tulane Health System Launches Minimally Invasive Robotic-Assisted Lung Biopsy Procedures
Arts in Medicine Mural Installation to Celebrate Survivorship & Inspire Hope
NOLA Bluedoo Set for September 17

June 2022
Researcher Receives $2.1 Million Grant to Study How Some Breast Cancers Evade the Immune System
Cancer Biologist to Lead Louisiana Cancer Research Center
Tulane Offers Minimally Invasive Skin Cancer Treatments That Can Save Lives
Dance to Make a Difference at the Seersucker & Sass Summer Gala
Krewe de Pink Presents Death by Chocolate...NOT Breast Cancer

May 2022
Three Tulane Investigators Receive Ladies Leukemia League Research Grants
NOLA Bluedoo is BACK!
Irma Thomas Gets Animated About the Importance of Clinical Research Trials
Return of the Pink Bra Run Was Fun – and Meaningful – for All!
Cancer Crusaders Raise $141K for Cancer Research at Tulane & LSU

April 2022
Researcher Awarded $2 Million NIGMS Grant to Study Biology of "Jumping Genes"
Tulane and New Orleans VA Researcher Receives Funding for Prostate Cancer Breakthrough
The Pink Bra Run is Back!  Join The Fun – In Person or Virtually
One Man Shoot Raises $130K for Prostate Cancer Research

March 2022
FDA Approves Pluvicto™ for Eligible Patients with Metastatic Castration-Resistant Prostate Cancer
New Findings May Lead to Personalized Treatments for Non-Clear Cell Renal Cell Carcinoma
"One Man Can Make a Difference" at the One Man Shoot Sporting Clays Event
March is Colorectal Cancer Awareness Month
Gunning for a Cure Sets Record - $340K Raised for Prostate Cancer Research

February 2022
Exploring the Role of "Activated" Foods in Human Health / Cancer Prevention
AACR Releases Report Outlining Impact of COVID-19 Pandemic on Cancer Research and Patient Care
Annual Gunning for a Cure Sporting Clays Event to Benefit Prostate Cancer Research
February is National Cancer Prevention Month: The ACS Reminds You to "Get Your Tests"
Annual "Pink Games" Surpass $250K Mark in Funds Raised for Patient Relief

January 2022
Study Links Louisiana's Severe Air Pollution to Dozens of Cancer Cases Each Year
Tulane Professor Elected to National Academy of Inventors
Krewe de Pink Donates $27.5K to Tulane's Breast Cancer Research Program

December 2021
$3.1 Million NCI Grant Supports Development of Potential Blood Test for Pancreatic Cancer
Looking Back and Looking Forward:  Our Year in Review

November 2021
Tulane University Study Uses Artificial Intelligence to Detect Colorectal Cancer
November is Lung Cancer Awareness Month: Tulane's Low-Dose CT Lung Screening Saves Lives
Let the "Great American Smokeout" Be Day One of Your Tobacco-Free Life
Blue Ribbon Soirée Celebrates 10th Year, Raising $155K for Prostate Cancer Research
Honoring Breast Cancer Survivorship

October 2021
Researcher Receives $1.7 Million Grant to Study Faulty DNA Repair & Cancer Risk
Tulane Urology Acquires First Single-Port Da Vinci Surgical Robot in the Gulf South
The Department of Surgery Welcomes David Pointer, MD
Cancer Crusaders Postpones 20th Annual Celebration of Life Luncheon

August 2021
Tulane Cancer Center Faculty Honored as "Top Doctors" in Their Fields
Join Us! Community Webinar on Prostate Cancer
Shedding Light on Light: Can Daytime Indoor Lighting Impact Your Health / Cancer Risk?
Fly Bayou: The Tiny Fruit Fly Helps Researchers in the Fight Against Cancer

July 2021
NCI's Annual Report to Nation: Overall Cancer Death Rates Continue to Decline
Liquid Biopsy Analysis Reveals Genetic Differences in Advanced Prostate Tumors
USPSTF Lowers Recommended Age to Begin Colon Cancer Screenings
Chancellor Donald, MD, Honored as a "Health Care Hero"

June 2021
Researcher Awarded $1.74 Million to Study Role of Virus in HIV-Associated Lung Cancer
Molecularly Targeted Radiation Therapy Extends Survival for Patients with Advanced Prostate Cancer
Head & Neck Cancer Surgical Clinic Opens on the Northshore
Cancer Crusaders Raise $81K for Research Despite Challenges of COVID-19
"Chocolate Extravaganza" to Benefit Breast Cancer Research

May 2021
Tulane World Leader in Molecularly Targeted Radiation Trials for Prostate Cancer
New Lung Cancer Screening Guidelines Include Broader Patient Population
Calling All Chocoholics!  Indulge Those Cravings And Make a Difference
Join Our 1st Interdisciplinary Urothelial Carcinoma Workshop

April 2021
Researcher Investigates Possible Link Between Obesity and Colon Cancer
New Faculty Member Broadens Tulane's Fruit Fly Research Program
$50K ACS Award to Assist Patients in Getting to Treatment Appointments
Pink Bra Run Goes VIRTUAL This Year!
Department of Urology Launches Men's Health Webinar Series

March 2021
Tulane Cancer Center First in Region to Offer MRI-Guided Perineal Prostate Biopsy
Doctors Should Address Reduced Sense of Taste and Smell in Cancer Patients, Tulane Study Says
Tulane Cancer Center Receives American Cancer Society Lodging Funds
Annual Sporting Clays Event Raises $180K for Prostate Cancer Research
Department of Urology Launches Men's Health Webinar Series

February 2021
Want a Rapid Second Opinion?  Tulane Cancer Center Doctors Are Standing By
Krewe de Pink Donates $25K to Breast Cancer Research Program
Annual Pink Games Surpass $200K in Funds Raised for Patient Relief
Department of Urology Launches Men's Health Webinar Series

December 2020
Progress in a Year of Unprecedented Challenge
Tulane Cancer Center Welcomes New Office of Clinical Research Director
Cancer Crusaders Raise $131K for Cancer Research at Tulane/LSU

November 2020
New Thoracic Oncologist Spearheads Development of Lung Cancer Program
Researchers Identify Marker That May Predict Whether Lung Cancer Likely to Spread
Tulane / ACCC Host Urothelial Carcinoma Workshop for Healthcare Professionals

October 2020
VIRTUAL Krewe de Pink Prom Benefits Breast Cancer Research Program
Kidney Cancer Association Hosts First Annual Virtual Patient Symposium
Tulane / ACCC Host Urothelial Carcinoma Workshop for Healthcare Professionals
Liver Cancer Treatment Showing Positive Results, Tulane Study Says
Community Webinar on Prostate Cancer Posted to YouTube
Many Thanks to Our 2020 NOLA Bluedoo Donors

September 2020
Join Our Community Webinar on Prostate Cancer
Patient Stories - Cyril Harvey, Jr.
NOLA Bluedoo is Canceled, BUT Prostate Cancer Research Support is Still Needed!

August 2020
Clinical Trial to Test Effectiveness of Drug in Treating Cancer Patients with Severe COVID-19
Join Us for our Virtual Community Seminar on Prostate Cancer
Gynecologic Oncology: Diverse Team of "Women Caring for Women"

June 2020
$792K ACS Grant to Help Metastatic Cancer Patients Understand/Access Palliative Care
Tulane Scientists Find a Switch to Flip and Turn off Breast Cancer Growth and Metastasis
$100K Kay Yow Cancer Fund Grant to Raise Clinical Trial Awareness In Minority Patients
Fruit Flies Help Shed Light on Tumor Formation, Migration and Growth

May 2020
Tulane Seeks Recovered COVID-19 Patients to Volunteer as Plasma Donors for Clinical Trial
A Ray of Hope in the Crisis, Dr. Kendra Harris Shines Light on Needs of Healthcare Providers
ACS Grant to Help Cancer Patients Overcome Transportation Barriers Especially Critical Now
Study Targeting Tumor Genetic Mutations Yields ‘Practice Changing’ Results for Prostate Cancer Treatment
Gunning for a Cure 2020 Raises $220K for Prostate Cancer Research

February 2020
Spike in U.S. Colorectal Cancer Rates From Age 49 to 50 Suggests Many Cases Likely Undiagnosed Before Screenings
Gunning for a Cure: Making a "Tremendous Difference" to Prostate Cancer Research
Radiation Oncologist Audrey Dang Returns to NOLA / Joins Tulane's Team
Death by Chocolate: A Sweet (and Savory!) Success
Pink Games Initiative Sets New Record in Effort to Assist Local Cancer Patients

January 2020
Radiation Oncology to Unveil New Linear Accelerator / Patient Care Area
Krewe de Pink Presents Death by Chocolate
Tulane Health First in Region to Offer Focal Therapy for Prostate Cancer

December 2019
Our Year in Review

November 2019
Kidney Cancer Day: Connecting Patients to Care Teams
Tulane Researcher is Editor of Journal Issue Honoring 40th Anniversary of Key Cancer Discovery
Pickup Truck for the Cure Raffle Extended - Winner to be Pulled June 1, 2020

October 2019
Tulane Study Reveals Dim Light at Night May Promote Breast Cancer Metastasis to Bone
Cancer Cells Turn to Cannibalism to Survive Chemotherapy
Tulane School of Medicine Welcomes Neuro-Oncologist Christopher Trevino, MD
Sixth Annual NOLA Bluedoo Raises $143K for Prostate Cancer Research
Cancer Crusaders Support Research/Celebrate Life at Annual Luncheon
Blue Ribbon Soiree Closing in on $1 Million Raised for Prostate Cancer Initiatives
Krewe de Pink Continues Their Support of Breast Cancer Research with $35K Gift

August 2019
Tulane Lakeside Hospital Now Offering 3D Breast Biopsy
16 Tulane Cancer Center Faculty Named "Top Docs" by New Orleans Magazine

July 2019
Flemington Team Awarded $2.3 Million For Virus-Related Malignancies Research
Our Summer Drive is ON!
Bryan Subaru / LLS Distribute Blankets, Art Kits & Messages of Hope to Cancer Patients

May 2019
Win a Truck & Help Cure Prostate Cancer
Researcher's Publication Honored as "Top 100" by Scientific Reports
New Multidisciplinary Prostate Cancer Clinic Enhances Care / Convenience
In the Pink: 4th Annual Pink Bra Run Raises Spirits/Funds for Breast Cancer Research
Cancer Crusaders Raise $171K for Tulane/LSU Cancer Research Programs

April 2019
Researcher Awarded $1.8 Million NCI Grant to Study New Targets for Rare Pediatric Cancer
Meet Us at the Levee: Pink Bra Run to Benefit Breast Cancer Research!
2019 One Man Shoot Continues the Mission - Making a Difference in Fighting Prostate Cancer

March 2019
Exploring "Dark Matter of Genomes" Could Shed Light on Cancer Risk
Joe W. & Dorothy Dorsett Brown Foundation Grant Supports Training of Aspiring Female Scientists
Colorectal Cancer Awareness Month Q & A - "Screening Saves Lives"

February 2019
Improving Access to Care Top Priority for New Genitourinary Cancers Expert
Study Finds Genetic Risks Associated With Prostate Cancer are Underestimated
Greenberg Family Endowment Boosts Fight Against Prostate Cancer
8th Annual One Man Shoot: Proving "One Man Can Make a Difference"
Gunning for a Cure Sets New Record, Raising $220K for Prostate Cancer Research
Tulane Medical Students Raise Money for Pediatric Cancer Research

January 2019
New Gynecologic Oncologist Aims to Reduce Cervical Cancer Rates in NOLA
Tulane Study Finds Potential Role for Personality Psychology in Cancer Care
Sixth Annual Gunning for a Cure Benefits Prostate Cancer Research
Student Athletes Provide Much-Needed Financial Assistance to Cancer Patients

December 2018
Improving Early Prostate Cancer Detection: Latest Technology Combines Imaging/Biopsy Tools to Improve Accuracy of Diagnosis
Advanced Cancer Patients Can Live Longer with Palliative Care, Tulane Study Says
Serve and Assist: Student Athletes Raise Funds for Patient Relief

November 2018
Prostate Cancer Patients Target of New $1.6M Tulane Study
Tulane Opens Novocure Trial for Patients with Stage 4 Non-Small Cell Lung Cancer
The Great American Smokeout ® - Quitting Starts Here!
8th Annual Blue Ribbon Soiree Sets Record, Raising $130K for Prostate Cancer Research
Krewe de Pink Celebrates New Orleans-Style, Donating $35K to Breast Cancer Research!

October 2018
Researcher Examines Role of DNA-Damaging Elements in Aging/Age-Related Diseases
Lynch Syndrome Can Lead to Cancer — Why Physicians Don't Test For It
Fifth NOLA Bluedoo a Record-Setting Success - Raises $193K for Prostate Cancer Research

August 2018
Tulane Cancer Center to Host Free Prostate Cancer Seminar
Fifth Annual NOLA Bluedoo Celebrates Prostate Cancer Survivorship New Orleans-Style
Tulane Doctor Elected to Elite Surgery College

July 2018
Tulane Welcomes Kendra Harris, MD, MSc - New Interim Chair of Radiation Oncology
Nakhle Saba Receives Ladies Leukemia League Grant to Study New Target for ALL
Bryan Subaru & LLS Bring Comfort to Patients Through Subaru Loves to Care Initiative

June 2018
Repurposed Drug Approach May Halt Spread of Cancer Cells
Tulane Head and Neck Experts Lead Call for HPV Vaccines
American Cancer Society Updates Colorectal Cancer Screening Guidelines

May 2018
Tulane Cancer Center Now Offering Imaging Tool to Detect Recurring Prostate Cancer
Grant Supports Smoking Cessation Education for Outpatient Mental Health Facilities
It's All About the Pink - Third Annual Pink Bra Run Supports Breast Cancer Research
Cancer Crusaders Donate $169,000 to Tulane/LSU Cancer Research Programs

April 2018
Grant Supports Smoking Cessation Program for Newly Diagnosed Cancer Patients
Med Student Takes Top Honors at Recent Meeting
State Rep. Julie Stokes to Lead 3rd Annual Pink Bra 5K Fun Run
7th Annual One Man Shoot Raises $130,000 for Prostate Cancer Research
Grant Supports Smoking Cessation Program For Newly Diagnosed Cancer Patients

March 2018
Researcher Explores Unique Genetic Mutation Associated with Liver Cancer
Healing Hands Across the Divide: Evolving to Address Cancer Disparities
Gunning for a Cure Raises $192K for Prostate Cancer Research

February 2018
Tulane Oncologist Outlines Prostate Cancer Treatment Advances in New England Journal of Medicine
Pink Games raise money — and hope — for patients fighting cancer

May 25, 2017
Prostate Cancer Immunotherapy Works Better for African-American Men
Cancer Crusaders Present Check for $210K
Free Skin Cancer Screenings Offered at Downtown Dermatology Clinic
National Cancer Survivor's Day
Celebration Planned
Second Annual Pink Bra Run -
Great Fun for a Great Cause

April 25, 2017
"Scarless Thyroid Surgery" on Agenda at Thyroid/Parathyroid & Skin Malignancies Symposia
Free Skin Cancer Screenings Offered at Covington Clinic
Second Annual Pink Bra Run Scheduled for Mother's Day Weekend

April 11, 2017
Tulane Researcher Shows Education Can Ease Fear in Cancer Patients
Thanks A Million!

March 10, 2017
Komen Grant Supports Study of Ductal Carcinoma In Situ
One Man Can Make a Difference: 6th Annual One Man Shoot Takes Aim at Prostate Cancer
2017 Gunning for a Cure Fundraiser Exceeds $500,000 Goal!

February 16, 2017
Leading Study Backs Hormone Therapy With Radiation for Recurrent Prostate Cancer
Victory Bell: Donation Helps Cancer Patients Celebrate Survivorship

February 3, 2017
Genetic Counselors Help Patients Better Understand Inherited Cancer Risk
Perez Family Targets Prostate Cancer Through Sporting Clays Event

January 26, 2017
Tulane Researchers Find Tumor-Suppressing Protein Actually Promotes Cancer
Tickled Pink: Local Student Athletes Assist Breast Cancer Patients